KUALA LUMPUR, Malaysia, Oct 5 (Bernama) — Universal Therapeutics, a multinational pharmaceutical and biotech company based in Malaysia, today announced that the Medical Device Authority of Malaysia (MDA) has approved the SARS-CoV-2 Antigen Rapid Test Kit (Saliva) for self-testing.
Manufactured by Triplex International Biosciences (China), the easy-to-use Rapid Test Kit can quickly detect the possibility of a COVID-19 infection, with a sensitivity of 100% specificity of 100% and accuracy of 100%. The test kit works by detecting the presence of the coronavirus nucleocapsid protein in saliva samples. Infants under the age of two are not recommended to use this test kit.
- US: Colorado woman dies weeks after firebombing at Gaza hostage protest
- Over 14 million people could die from US foreign aid cuts: study
- UN: Most world heritage sites at risk of drought or flooding
- Yemen’s Houthis Claim Missile Strike On Israel’s Ben Gurion Airport
- Barge Capsized In Gulf Of Suez: Egyptian Ministry
- Explainer: Why Was Thai PM Paetongtarn Suspended From Duty?
- S. Korea’s Top Prosecutor Offers To Resign
- UN Security Council Extends Mandate Of Peacekeeping Force On Golan Heights
- Egypt’s FM Discusses Iranian Nuclear Issue With Iran’s FM, IAEA Chief
- Gunmen Shot Dead Four In India’s Manipur